ClinConnect ClinConnect Logo
Search / Trial NCT06735040

Effect of Photobiomodulation Therapy in Patients With Hashimoto's Thyroiditis

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Dec 11, 2024

Trial Information

Current as of June 09, 2025

Completed

Keywords

Anxiety Depression Fatigue Photobiomodulation Therapy Low Level Laser Therapy

ClinConnect Summary

Photobiomodulation therapy (PMBT) induces a wide range of molecular, cellular and tissue-based therapeutic effects through a biostimulation process by inducing a photochemical reaction in the cell. Some investigations show useful effects of this treatment with regard to thyroid function, autoimmunity and vascularisation in patients with Hashimoto's thyroiditis (HT). However, little is known about the efficacy of PMBT on neuromuscular symptoms and behavioural status. Therefore, in this study we aim to contribute the present literature on PMBT and to determine the clinical efficacy of PMBT. T...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The study included patients over the age of eighteen years who were diagnosed with HT by a specialist physician and followed up with LT4 treatment.
  • Exclusion Criteria:
  • Exclusion criteria were acute infection, use of immunosuppressants, immunostimulants and drugs that interfere with the production, transport and metabolism of thyroid hormones (e.g. corticosteroids, lithium and amiodarone), thyroid nodules, tracheal stenosis, history of serious illness (e.g. cancer, ischaemic coronary artery disease, stroke, renal and liver failure), history of exposure to ionising radiation or neoplasia in the cervical region, malignancy and thyroid surgery; cancer, ischaemic coronary artery disease, stroke, renal and hepatic failure), history of exposure to ionising radiation or neoplasia in the cervical region, history of malignancy and thyroid surgery, hypothyroidism caused by postpartum thyroiditis, pregnancy and lactation, neurological and psychiatric disorders.

About Istanbul Medipol University Hospital

Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Şükriye Leyla ALTUNTAŞ

Study Director

Medipol University

Murat ATMACA

Study Chair

Medipol University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported